Pro Medicus Limited Reports Strong Half-Year Growth

Pro Medicus Limited ( (PMCUF) ) has released its Q2 earnings. Here is a breakdown of the information Pro Medicus Limited presented to its investors.

Pro Medicus Limited is an Australian company specializing in software applications for the healthcare industry, with a focus on radiology information systems and picture archiving communications systems.

In its latest earnings report for the half-year ending December 31, 2024, Pro Medicus Limited announced a robust financial performance, showcasing significant growth in profits and revenue. The company reported an after-tax profit of $51.74 million, marking a 42.7% increase from the previous year, alongside a revenue rise of 31.1% to $97.20 million.

The company highlighted substantial growth in its North American operations, with revenue from this region increasing by 34.6%. Pro Medicus completed major implementations for several health institutions, including Oregon Health & Science University and Moffitt Cancer Centre. Additionally, new contracts and extensions worth over A$500 million were secured, indicating strong future revenue streams. The European and Australian markets also saw revenue growth, albeit at a slower pace compared to North America.

Pro Medicus continues to invest in research and development to maintain its competitive advantage, while also benefiting from increased exam volumes and strong cash reserves, which grew by 17.7% to $182.33 million. The company remains debt-free and announced a fully franked interim dividend of 25.0 cents per share.

Looking ahead, Pro Medicus aims to further expand its presence in key international markets, with a focus on academic hospitals and private imaging centers. The company is well-positioned to capitalize on new opportunities and sustain its growth trajectory in the healthcare technology sector.